AKEBIA THERAPEUTICS, INC. (AKBA) Operating margin 2016–2025
AKEBIA THERAPEUTICS, INC. (AKBA) operating margin by fiscal year — reported operating income divided by reported revenue.
9.9%FY2025 · since FY2016: -8889.9% → 9.9%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 9.9% | +41.5 pp |
| FY2024 | -31.5% | -7.7 pp |
| FY2023 | -23.8% | +3.9 pp |
| FY2022 | -27.6% | +97.4 pp |
| FY2021 | -125.0% | +3.3 pp |
| FY2020 | -128.2% | -42.8 pp |
| FY2019 | -85.5% | +0.3 pp |
| FY2018 | -85.8% | -43.5 pp |
| FY2017 | -42.3% | +8847.6 pp |
| FY2016 | -8889.9% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More AKBA financial trends
AKBA RevenueAKBA Net incomeAKBA Net marginAKBA Gross profitAKBA Gross marginAKBA Operating incomeAKBA Operating cash flowAKBA Free cash flowAKBA Capital expendituresAKBA Return on equityAKBA Stock buybacksAKBA Dividends paidAKBA Total assetsAKBA Total liabilitiesAKBA Shareholders’ equityAKBA overview →